<document id="DDI-DrugBank.d422">
    <sentence id="DDI-DrugBank.d422.s0" text="Catecholamine-depleting drugs, e.g., reserpine, may have an additive effect when given with beta blocking agents.">
        <entity charOffset="37-45" id="DDI-DrugBank.d422.s0.e0" text="reserpine" type="drug" />
        <entity charOffset="92-111" id="DDI-DrugBank.d422.s0.e1" text="beta blocking agents" type="group" />
        <pair ddi="true" e1="DDI-DrugBank.d422.s0.e0" e2="DDI-DrugBank.d422.s0.e1" id="DDI-DrugBank.d422.s0.p0" type="effect" />
    </sentence>
    <sentence id="DDI-DrugBank.d422.s1" text="Patients treated concurrently with BREVIBLOC (esmolol HCl) and a catecholamine depletor should therefore be closely observed for evidence of hypotension or marked bradycardia, which may result in vertigo, syncope, or postural hypotension.">
        <entity charOffset="35-43" id="DDI-DrugBank.d422.s1.e0" text="BREVIBLOC" type="brand" />
        <entity charOffset="46-56" id="DDI-DrugBank.d422.s1.e1" text="esmolol HCl" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d422.s1.e0" e2="DDI-DrugBank.d422.s1.e1" id="DDI-DrugBank.d422.s1.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d422.s3" text="BREVIBLOC concentrations were equivocally higher when given with warfarin, but this is not likely to be clinically important.">
        <entity charOffset="0-8" id="DDI-DrugBank.d422.s3.e0" text="BREVIBLOC" type="brand" />
        <entity charOffset="65-72" id="DDI-DrugBank.d422.s3.e1" text="warfarin" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d422.s3.e0" e2="DDI-DrugBank.d422.s3.e1" id="DDI-DrugBank.d422.s3.p0" type="mechanism" />
    </sentence>
    <sentence id="DDI-DrugBank.d422.s5" text="Digoxin did not affect BREVIBLOC pharmacokinetics.">
        <entity charOffset="0-6" id="DDI-DrugBank.d422.s5.e0" text="Digoxin" type="drug" />
        <entity charOffset="23-31" id="DDI-DrugBank.d422.s5.e1" text="BREVIBLOC" type="brand" />
        <pair ddi="false" e1="DDI-DrugBank.d422.s5.e0" e2="DDI-DrugBank.d422.s5.e1" id="DDI-DrugBank.d422.s5.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d422.s8" text="The effect of BREVIBLOC on the duration of succinylcholine-induced neuromuscular blockade was studied in patients undergoing surgery.">
        <entity charOffset="14-22" id="DDI-DrugBank.d422.s8.e0" text="BREVIBLOC" type="drug" />
        <entity charOffset="43-57" id="DDI-DrugBank.d422.s8.e1" text="succinylcholine" type="drug" />
        <pair ddi="false" e1="DDI-DrugBank.d422.s8.e0" e2="DDI-DrugBank.d422.s8.e1" id="DDI-DrugBank.d422.s8.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d422.s9" text="The onset of neuromuscular blockade by succinylcholine was unaffected by BREVIBLOC, but the duration of neuromuscular blockade was prolonged from 5 minutes to 8 minutes.">
        <entity charOffset="39-53" id="DDI-DrugBank.d422.s9.e0" text="succinylcholine" type="drug" />
        <entity charOffset="73-81" id="DDI-DrugBank.d422.s9.e1" text="BREVIBLOC" type="brand" />
        <pair ddi="true" e1="DDI-DrugBank.d422.s9.e0" e2="DDI-DrugBank.d422.s9.e1" id="DDI-DrugBank.d422.s9.p0" type="effect" />
    </sentence>
    <sentence id="DDI-DrugBank.d422.s13" text="Caution should be exercised when considering the use of BREVIBLOC and verapamil in patients with depressed myocardial function.">
        <entity charOffset="56-64" id="DDI-DrugBank.d422.s13.e0" text="BREVIBLOC" type="brand" />
        <entity charOffset="70-78" id="DDI-DrugBank.d422.s13.e1" text="verapamil" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d422.s13.e0" e2="DDI-DrugBank.d422.s13.e1" id="DDI-DrugBank.d422.s13.p0" type="advise" />
    </sentence>
    </document>